Literature DB >> 26809711

Atherosclerosis and Nanotechnology: Diagnostic and Therapeutic Applications.

Jeremy D Kratz1,2, Ashish Chaddha2, Somnath Bhattacharjee1,3, Sascha N Goonewardena4,5.   

Abstract

Over the past several decades, tremendous advances have been made in the understanding, diagnosis, and treatment of coronary artery disease (CAD). However, with shifting demographics and evolving risk factors we now face new challenges that must be met in order to further advance are management of patients with CAD. In parallel with advances in our mechanistic appreciation of CAD and atherosclerosis, nanotechnology approaches have greatly expanded, offering the potential for significant improvements in our diagnostic and therapeutic management of CAD. To realize this potential we must go beyond to recognize new frontiers including knowledge gaps between understanding atherosclerosis to the translation of targeted molecular tools. This review highlights nanotechnology applications for imaging and therapeutic advancements in CAD.

Entities:  

Keywords:  Atherosclerosis; Endothelial cell; Inflammation; Macrophage; Molecular imaging; Nanotechnology

Mesh:

Year:  2016        PMID: 26809711      PMCID: PMC4791194          DOI: 10.1007/s10557-016-6649-2

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN: 0920-3206            Impact factor:   3.727


  67 in total

1.  Imaging intraplaque inflammation in carotid atherosclerosis with 11C-PK11195 positron emission tomography/computed tomography.

Authors:  Oliver Gaemperli; Joseph Shalhoub; David R J Owen; Frederic Lamare; Saga Johansson; Naghmeh Fouladi; Alun H Davies; Ornella E Rimoldi; Paolo G Camici
Journal:  Eur Heart J       Date:  2011-09-19       Impact factor: 29.983

2.  Identifying inflamed carotid plaques using in vivo USPIO-enhanced MR imaging to label plaque macrophages.

Authors:  Rikin A Trivedi; Chinthake Mallawarachi; Jean-Marie U-King-Im; Martin J Graves; Jo Horsley; Martin J Goddard; Andrew Brown; Liqun Wang; Peter J Kirkpatrick; John Brown; Jonathan H Gillard
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-04-20       Impact factor: 8.311

3.  FMT-XCT: in vivo animal studies with hybrid fluorescence molecular tomography-X-ray computed tomography.

Authors:  Angelique Ale; Vladimir Ermolayev; Eva Herzog; Christian Cohrs; Martin Hrabé de Angelis; Vasilis Ntziachristos
Journal:  Nat Methods       Date:  2012-05-06       Impact factor: 28.547

Review 4.  Imaging macrophages with nanoparticles.

Authors:  Ralph Weissleder; Matthias Nahrendorf; Mikael J Pittet
Journal:  Nat Mater       Date:  2014-02       Impact factor: 43.841

5.  The napkin-ring sign indicates advanced atherosclerotic lesions in coronary CT angiography.

Authors:  Pál Maurovich-Horvat; Christopher L Schlett; Hatem Alkadhi; Masataka Nakano; Fumiyuki Otsuka; Paul Stolzmann; Hans Scheffel; Maros Ferencik; Matthias F Kriegel; Harald Seifarth; Renu Virmani; Udo Hoffmann
Journal:  JACC Cardiovasc Imaging       Date:  2012-12

6.  Noninvasive vascular cell adhesion molecule-1 imaging identifies inflammatory activation of cells in atherosclerosis.

Authors:  Matthias Nahrendorf; Farouc A Jaffer; Kimberly A Kelly; David E Sosnovik; Elena Aikawa; Peter Libby; Ralph Weissleder
Journal:  Circulation       Date:  2006-09-25       Impact factor: 29.690

7.  Atherosclerotic plaque composition: analysis with multicolor CT and targeted gold nanoparticles.

Authors:  David P Cormode; Ewald Roessl; Axel Thran; Torjus Skajaa; Ronald E Gordon; Jens-Peter Schlomka; Valentin Fuster; Edward A Fisher; Willem J M Mulder; Roland Proksa; Zahi A Fayad
Journal:  Radiology       Date:  2010-07-28       Impact factor: 11.105

Review 8.  The powerful microbubble: from bench to bedside, from intravascular indicator to therapeutic delivery system, and beyond.

Authors:  Steven B Feinstein
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-08       Impact factor: 4.733

9.  Increased endoplasmic reticulum stress in atherosclerotic plaques associated with acute coronary syndrome.

Authors:  Masafumi Myoishi; Hiroyuki Hao; Tetsuo Minamino; Kouki Watanabe; Kensaku Nishihira; Kinta Hatakeyama; Yujiro Asada; Ken-ichiro Okada; Hatsue Ishibashi-Ueda; Giulio Gabbiani; Marie-Luce Bochaton-Piallat; Naoki Mochizuki; Masafumi Kitakaze
Journal:  Circulation       Date:  2007-08-20       Impact factor: 29.690

10.  Inhibiting macrophage proliferation suppresses atherosclerotic plaque inflammation.

Authors:  Jun Tang; Mark E Lobatto; Laurien Hassing; Susanne van der Staay; Sarian M van Rijs; Claudia Calcagno; Mounia S Braza; Samantha Baxter; Francois Fay; Brenda L Sanchez-Gaytan; Raphaël Duivenvoorden; Hendrik Sager; Yaritzy M Astudillo; Wei Leong; Sarayu Ramachandran; Gert Storm; Carlos Pérez-Medina; Thomas Reiner; David P Cormode; Gustav J Strijkers; Erik S G Stroes; Filip K Swirski; Matthias Nahrendorf; Edward A Fisher; Zahi A Fayad; Willem J M Mulder
Journal:  Sci Adv       Date:  2015-04       Impact factor: 14.136

View more
  3 in total

Review 1.  Neurotheranostics as personalized medicines.

Authors:  Bhavesh D Kevadiya; Brendan M Ottemann; Midhun Ben Thomas; Insiya Mukadam; Saumya Nigam; JoEllyn McMillan; Santhi Gorantla; Tatiana K Bronich; Benson Edagwa; Howard E Gendelman
Journal:  Adv Drug Deliv Rev       Date:  2018-10-26       Impact factor: 15.470

2.  Towards clinically translatable in vivo nanodiagnostics.

Authors:  Seung-Min Park; Amin Aalipour; Ophir Vermesh; Jung Ho Yu; Sanjiv S Gambhir
Journal:  Nat Rev Mater       Date:  2017-05-03       Impact factor: 66.308

Review 3.  Recent strategies to design vascular theranostic nanoparticles.

Authors:  Mukesh K Gupta; Yunki Lee; Timothy C Boire; Jung-Bok Lee; Won Shik Kim; Hak-Joon Sung
Journal:  Nanotheranostics       Date:  2017-04-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.